146
Views
5
CrossRef citations to date
0
Altmetric
Theme: Schizophrenia - Review

Unmet treatment needs in schizophrenia patients: is asenapine a potential therapeutic option?

, , , , , , , , & show all
Pages 989-1006 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leslie Citrome. (2014) Asenapine review, part II: clinical efficacy, safety and tolerability. Expert Opinion on Drug Safety 13:6, pages 803-830.
Read now
Thomas M Penders, Salina Agarwal & Rachel Rohaidy. (2013) Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression. Neuropsychiatric Disease and Treatment 9, pages 463-465.
Read now

Articles from other publishers (3)

Toshihiko Kinoshita, Yoshiteru Takekita, Shuichi Hiraoka, Fumihiro Tamura & Yasuhiro Iwama. (2023) Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks ( P06125 )—Secondary publication . Neuropsychopharmacology Reports.
Crossref
Toshihiko Kinoshita, Ya-Mei Bai, Jong-Hoon Kim, Mutsuo Miyake & Nobuyuki Oshima. (2016) Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study. Psychopharmacology 233:14, pages 2663-2674.
Crossref
Richard C McEachin. (2011) Overlap of genetic influences in phenotypes classically categorized as psychiatric vs medical disorders. World Journal of Medical Genetics 1:1, pages 4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.